Understanding MLR Silos with Enterprise Content Management Solution
MLR inefficiencies can cause severe content approval lags, leading to compliance risks, higher operational costs, and missed market opportunities.
The root of the problem lies in MLR silos—Medical, Legal, and Regulatory teams who operate in isolated systems with outdated workflows. This disorganization creates approval bottlenecks, less collaboration, and delays in content from reaching its intended audience.
A more structured approach is needed. Enterprise content management solution streamlines workflow automation, improving collaboration, and accelerating approvals while maintaining compliance. Let’s learn more.
The Root of the Problem: Understanding MLR Silos
What Are MLR Silos?
MLR silos occur when Medical, Legal, and Regulatory teams work in disconnected review processes, causing approval delays, compliance risks, and increased costs. Even industry leaders struggle with outdated systems and fragmented collaboration, hindering efficient workflow automation.
Bottleneck Approvals: MLR workflows can drag on for weeks, delaying product launches and marketing campaigns. A Veeva Systems study found that 65% of pharma professionals struggle with slow approvals.
Compliance Risk: Inconsistent messaging or overlooked compliance details can invite FDA scrutiny. Many large pharmaceuticals have faced regulatory action over content non-compliance. In one instance, the FDA issued a letter to one organization regarding misleading claims in their “When Migraine Strikes” TV advertisement featuring Serena Williams. Similarly, a European organization has recently been under investigation by Chinese authorities for medical-insurance fraud and illegal drug imports.
Siloed Teams, Scattered Efforts: Without a unified review system, there can be redundant tasks, miscommunication, and approval. Hidden Cost Sinkholes: Every additional approval round drives up labor costs and missed market opportunities. Pharma companies collectively lose millions each year to inefficiencies in MLR workflows.
XpConnect® is the Enterprise Content Management Solution for MLR Silos
Inefficient Medical, Legal, and Regulatory (MLR) workflows have long plagued pharmaceutical companies, leading to approval delays, compliance risks, and high operational costs. Companies that have optimized their MLR workflows have seen a 57% reduction in review cycle times and a 55% drop in time spent in review meetings.
Additionally, fines across the pharmaceutical industry related to the False Claims Act total in the billions of dollars, with individual firms often penalized millions of dollars per infraction.
The Solution for MLR Optimization
Enterprise content management is a centralized system that streamlines MLR content reviews. XpConnect® is our modern enterprise content management solution designed to eliminate these challenges.
- XpConnect® connects effortlessly with existing pharma marketing ecosystems Veeva Vault and Adobe AEM.
- Adheres to FDA, EMA, and global regulatory standards, reducing compliance risks and ensuring consistency.
- Designed to handle increasing content volumes without compromising accuracy or speed.
XpConnect® in Action
Novo Nordisk faced significant delays in MLR approvals due to fragmented content and manual processes. By implementing our XpConnect®, the team achieved a 60+% improvement in MLR submission times, successfully eliminating duplicate reviews and automating content processes.
The Future of MLR Review is with ECM
MLR silos are a major barrier to efficient pharma marketing. With XpConnect®, pharma brands can eliminate inefficiencies, accelerate content approvals, and maintain regulatory compliance. Discover how XpConnect® can streamline your content approvals today.
